167 related articles for article (PubMed ID: 15647233)
1. States' allocations of funds from the tobacco master settlement agreement.
Sloan FA; Allsbrook JS; Madre LK; Masselink LE; Mathews CA
Health Aff (Millwood); 2005; 24(1):220-7. PubMed ID: 15647233
[TBL] [Abstract][Full Text] [Related]
2. Rural economic development vs. tobacco control? Tensions underlying the use of tobacco settlement funds.
Austin WD; Altman D
J Public Health Policy; 2000; 21(2):129-56. PubMed ID: 10881452
[TBL] [Abstract][Full Text] [Related]
3. Are State legislatures responding to public opinion when allocating funds for tobacco control programs?
Snyder A; Falba T; Busch S; Sindelar J
Health Promot Pract; 2004 Jul; 5(3 Suppl):35S-45S. PubMed ID: 15231095
[TBL] [Abstract][Full Text] [Related]
4. The 1998 Master Settlement Agreement: a public health opportunity realized--or lost?
Niemeyer D; Miner KR; Carlson LM; Baer K; Shorty L
Health Promot Pract; 2004 Jul; 5(3 Suppl):21S-32S. PubMed ID: 15231093
[TBL] [Abstract][Full Text] [Related]
5. Securitization of tobacco settlement payments to reduce states' conflict of interest.
Sindelar J; Falba T
Health Aff (Millwood); 2004; 23(5):188-93. PubMed ID: 15371384
[TBL] [Abstract][Full Text] [Related]
6. Public opinion analysis regarding the uses of master settlement agreement (MSA) funds.
Friis RH; Safer AM; Piane GM
Public Health; 2004 Apr; 118(3):190-200. PubMed ID: 15003408
[TBL] [Abstract][Full Text] [Related]
7. Press coverage of public expenditure of Master Settlement Agreement funds: how are non-tobacco control related expenditures represented?
Clegg Smith KM; Wakefield MA; Nichter M
Tob Control; 2003 Sep; 12(3):257-63. PubMed ID: 12958383
[TBL] [Abstract][Full Text] [Related]
8. Determinants of states' allocations of the master settlement agreement payments.
Sloan FA; Carlisle ES; Rattliff JR; Trogdon J
J Health Polit Policy Law; 2005 Aug; 30(4):643-86. PubMed ID: 16318165
[TBL] [Abstract][Full Text] [Related]
9. Arkansas Tobacco Settlement Proceeds Act of 2000: results from education and engagement with policy makers and the public.
Thompson JW; Ryan KW; Tyson S; Munir C
Health Promot Pract; 2004 Jul; 5(3 Suppl):57S-63S. PubMed ID: 15231097
[TBL] [Abstract][Full Text] [Related]
10. A qualitative study of post-settlement influences on State tobacco control funding.
Austin-Lane J; Girasek DC; Barbour GL
Health Promot Pract; 2004 Jul; 5(3 Suppl):46S-56S. PubMed ID: 15231096
[TBL] [Abstract][Full Text] [Related]
11. The impact of tobacco control program expenditures on aggregate cigarette sales: 1981-2000.
Farrelly MC; Pechacek TF; Chaloupka FJ
J Health Econ; 2003 Sep; 22(5):843-59. PubMed ID: 12946462
[TBL] [Abstract][Full Text] [Related]
12. Impacts of the Master Settlement Agreement on the tobacco industry.
Sloan FA; Mathews CA; Trogdon JG
Tob Control; 2004 Dec; 13(4):356-61. PubMed ID: 15564618
[TBL] [Abstract][Full Text] [Related]
13. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
14. Advocating for dollars: unanticipated lessons in allocating Master Settlement Agreement funds.
Wilbur P
Health Promot Pract; 2004 Jul; 5(3 Suppl):33S-34S. PubMed ID: 15231094
[No Abstract] [Full Text] [Related]
15. The state tobacco settlement: where do we stand?
Clarke LK
ORL Head Neck Nurs; 2006; 24(4):20-1. PubMed ID: 17390708
[TBL] [Abstract][Full Text] [Related]
16. How did the Master Settlement Agreement change tobacco industry expenditures for cigarette advertising and promotions?
Pierce JP; Gilpin EA
Health Promot Pract; 2004 Jul; 5(3 Suppl):84S-90S. PubMed ID: 15231101
[TBL] [Abstract][Full Text] [Related]
17. Litigation and the value of tobacco companies.
Sloan FA; Trogdon JG; Mathews CA
J Health Econ; 2005 May; 24(3):427-47. PubMed ID: 15811537
[TBL] [Abstract][Full Text] [Related]
18. State expenditures for tobacco-control programs and the tobacco settlement.
Gross CP; Soffer B; Bach PB; Rajkumar R; Forman HP
N Engl J Med; 2002 Oct; 347(14):1080-6. PubMed ID: 12362010
[TBL] [Abstract][Full Text] [Related]
19. Will the master settlement agreement achieve a lasting legacy?
Healton CG; Haviland ML; Vargyas E
Health Promot Pract; 2004 Jul; 5(3 Suppl):12S-17S. PubMed ID: 15231091
[TBL] [Abstract][Full Text] [Related]
20. Tobacco industry direct marketing after the Master Settlement Agreement.
Lewis MJ; Yulis SG; Delnevo C; Hrywna M
Health Promot Pract; 2004 Jul; 5(3 Suppl):75S-83S. PubMed ID: 15231100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
